4D Molecular Therapeutics, Inc 10-Q for FY2021 Q3
4D Molecular Therapeutics, Inc. (FDMT)
10-Q
2021-11-10
For: 2021-09-30
View Original
Added on
April 08, 2026
About this 10-Q
4D Molecular Therapeutics, Inc filed this 10-Q on November 10, 2021, covering the quarter ended September 30, 2021 (FY2021 Q3).
Headline figures
Quarter ended September 30, 2021, as reported in this filing, compared with the same period a year earlier where the filing states it.
- Revenue
- $1.37M
- down 81.6% from $7.42M a year earlier
- Net loss
- $22.24M
- compared with a net loss of $7.83M a year earlier